List of Tables
Table 1. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Trends
Table 3. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Drivers
Table 4. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Challenges
Table 5. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Restraints
Table 6. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Share by Manufacturer, 2017-2022
Table 13. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Manufacturer, (K MT), 2017-2022
Table 14. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Share by Manufacturer, 2017-2022
Table 15. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Manufacturer (2017-2022) & (USD/MT)
Table 16. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dipeptidyl Peptidase IV (DPP-IV) Inhibitors as of 2021)
Table 18. Top Players of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Type
Table 20. Date of International Manufacturers Enter into Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Players, (K MT), 2020, 2021 & 2022
Table 26. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume by Region (2017-2022) & (K MT)
Table 29. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume Forecast by Region (2023-2028) & (K MT)
Table 30. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume by Country (2017-2028) & (K MT)
Table 33. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume by Region (2017-2028) & (K MT)
Table 35. Asia Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume by Country (2017-2028) & (K MT)
Table 37. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume by Country (2017-2028) & (K MT)
Table 39. Latin Americaa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume by Country (2017-2028) & (K MT)
Table 41. Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. AstraZeneca Corporation Information
Table 43. AstraZeneca Description and Business Overview
Table 44. AstraZeneca Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 45. AstraZeneca Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product
Table 46. AstraZeneca Recent Development
Table 47. Boehringer Corporation Information
Table 48. Boehringer Description and Business Overview
Table 49. Boehringer Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 50. Boehringer Product
Table 51. Boehringer Recent Development
Table 52. Eli Lilly Corporation Information
Table 53. Eli Lilly Description and Business Overview
Table 54. Eli Lilly Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 55. Eli Lilly Product
Table 56. Eli Lilly Recent Development
Table 57. Merck Corporation Information
Table 58. Merck Description and Business Overview
Table 59. Merck Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 60. Merck Product
Table 61. Merck Recent Development
Table 62. Mitsubishi Tanabe Pharma Corporation Information
Table 63. Mitsubishi Tanabe Pharma Description and Business Overview
Table 64. Mitsubishi Tanabe Pharma Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 65. Mitsubishi Tanabe Pharma Product
Table 66. Mitsubishi Tanabe Pharma Recent Development
Table 67. Novartis Corporation Information
Table 68. Novartis Description and Business Overview
Table 69. Novartis Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 70. Novartis Product
Table 71. Novartis Recent Development
Table 72. Takeda Corporation Information
Table 73. Takeda Description and Business Overview
Table 74. Takeda Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 75. Takeda Product
Table 76. Takeda Recent Development
Table 77. Key Raw Materials Lists
Table 78. Raw Materials Key Suppliers Lists
Table 79. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Customers List
Table 80. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Distributors List
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Picture
Figure 2. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size 2017-2028 (US$ Million)
Figure 4. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales 2017-2028 (K MT)
Figure 5. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size 2017-2028 (US$ Million)
Figure 7. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales 2017-2028 (K MT)
Figure 8. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Share in Global, in Volume (K MT) 2017-2028
Figure 10. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Report Years Considered
Figure 11. Product Picture of Sitagliptin
Figure 12. Product Picture of Vildagliptin
Figure 13. Product Picture of Saxagliptin
Figure 14. Product Picture of Linagliptin
Figure 15. Product Picture of Others
Figure 16. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Share by Type in 2022 & 2028
Figure 17. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value by Type (2017-2028) & (US$ Million)
Figure 18. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Value by Type (2017-2028)
Figure 19. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2017-2028) & (K MT)
Figure 20. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Volume by Type (2017-2028)
Figure 21. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Type (2017-2028) & (USD/MT)
Figure 22. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Share by Type in 2022 & 2028
Figure 23. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value by Type (2017-2028) & (US$ Million)
Figure 24. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Value by Type (2017-2028)
Figure 25. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2017-2028) & (K MT)
Figure 26. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Volume by Type (2017-2028)
Figure 27. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Type (2017-2028) & (USD/MT)
Figure 28. Product Picture of Hospital Pharmacies
Figure 29. Product Picture of Retail Pharmacies
Figure 30. Product Picture of Online Pharmacies
Figure 31. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Share by Application in 2022 & 2028
Figure 32. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value by Application (2017-2028) & (US$ Million)
Figure 33. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Value by Application (2017-2028)
Figure 34. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2017-2028) & (K MT)
Figure 35. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Volume by Application (2017-2028)
Figure 36. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Application (2017-2028) & (USD/MT)
Figure 37. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Share by Application in 2022 & 2028
Figure 38. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value by Application (2017-2028) & (US$ Million)
Figure 39. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Value by Application (2017-2028)
Figure 40. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2017-2028) & (K MT)
Figure 41. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Volume by Application (2017-2028)
Figure 42. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Application (2017-2028) & (USD/MT)
Figure 43. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 44. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 45. U.S. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. Canada Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 48. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 49. Germany Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. France Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. U.K. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Italy Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Russia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 55. Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 56. China Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Japan Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. South Korea Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. India Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Australia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Taiwan Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Indonesia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Thailand Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Malaysia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Philippines Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 67. Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 68. Mexico Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Brazil Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Argentina Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Middle East & Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 72. Middle East & Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 73. Turkey Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. Saudi Arabia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 75. UAE Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 76. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Value Chain
Figure 77. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Production Process
Figure 78. Channels of Distribution
Figure 79. Distributors Profiles
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed
